FTC Report Finds Decline In Potential Pay-For-Delay Deals
The U.S. Federal Trade Commission on Monday issued a report finding that the number of potentially anti-competitive patent settlements over the past fiscal year between branded pharmaceutical companies and generic-drug makers...To view the full article, register now.
Already a subscriber? Click here to view full article